Valuation: Tianda Pharmaceuticals Limited

Market Cap 191M 24.39M 21.84M 20.09M 18.21M 34.03M 2.32B 34.67M 240M 96.19M 1.22B 91.54M 89.59M 3.84B P/E 2024
-5.92x
P/E 2025 -3.96x
Enterprise Value 253M 32.2M 28.84M 26.53M 24.03M 44.93M 3.06B 45.77M 316M 127M 1.61B 121M 118M 5.07B EV / Sales 2024
1.21x
EV / Sales 2025 1.05x
Free-Float
20.57%
Yield 2024 *
-
Yield 2025 -
1 week-3.26%
1 month-24.58%
3 months-14.42%
6 months-9.18%
Current year-31.01%
1 week 0.09
Extreme 0.089
0.09
1 month 0.08
Extreme 0.083
0.12
Current year 0.08
Extreme 0.081
0.14
1 year 0.08
Extreme 0.081
0.14
3 years 0.08
Extreme 0.081
0.28
5 years 0.08
Extreme 0.081
0.43
10 years 0.08
Extreme 0.081
0.51
Manager TitleAgeSince
Chief Executive Officer 57 13/12/2009
Corporate Secretary 71 -
Director TitleAgeSince
Director/Board Member 60 31/12/2003
Chairman 57 13/12/2009
Director/Board Member 79 09/04/2008
Date Insider Type Main position Quantity % Market Cap. Importance
21/12/22 Other

Chief Executive Officer

640,000 0.0298%
20/12/22 Other

Chief Executive Officer

770,000 0.0358%
16/12/22 Other

Chief Executive Officer

1,590,000 0.0740%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.26%-34.07%-55.50% 24.39M
-0.86%+10.07%+57.05%+142.64% 1,263B
-1.78%+0.81%+44.12%+78.68% 658B
-2.08%+0.29%+35.67%+100.73% 521B
-1.62%0.00%+52.79%+66.49% 391B
-0.71%+5.29%+79.48%+43.95% 369B
-1.76%+3.11%+32.10%+55.26% 307B
-0.77%+7.66%+11.92%+33.55% 290B
-0.81%+3.92%+55.94%+73.32% 252B
-1.03%+5.82%+37.59%+106.73% 212B
Average -1.15%+4.98%+37.26%+64.58% 426.2B
Weighted average by Cap. -1.28%+6.60%+48.09%+92.52%

Financials

2024 2025
Net sales 330M 42.06M 37.67M 34.65M 31.39M 58.68M 3.99B 59.78M 413M 166M 2.1B 158M 154M 6.62B 323M 41.16M 36.87M 33.91M 30.73M 57.44M 3.91B 58.51M 404M 162M 2.06B 154M 151M 6.48B
Net income -61.37M -7.82M -7.01M -6.44M -5.84M -10.91M -743M -11.12M -76.85M -30.85M -391M -29.36M -28.73M -1.23B -70M -8.92M -7.99M -7.35M -6.66M -12.45M -847M -12.68M -87.65M -35.19M -446M -33.48M -32.77M -1.41B
Net Debt 35.61M 4.54M 4.07M 3.74M 3.39M 6.33M 431M 6.45M 44.6M 17.9M 227M 17.04M 16.67M 715M 61.25M 7.81M 6.99M 6.43M 5.83M 10.89M 741M 11.1M 76.7M 30.79M 390M 29.3M 28.68M 1.23B
Projected Income Statement - Annual - Tianda Pharmaceuticals Limited
Logo Tianda Pharmaceuticals Limited
Tianda Pharmaceuticals Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Pharmaceuticals and Medical Technologies Business segment is mainly engaged in the sale of pharmaceutical, biotechnology and healthcare products. The segment is also engaged in the provision of contract development and manufacturing organisation (CDMO) services. The Chinese Medicine Business segment is mainly engaged in the sale of Chinese medicine products. The Medical and Healthcare Services segment is mainly engaged in the sale of healthcare and Chinese medicine products. The segment is also engaged in the provision of Chinese medical services. Additionally, the Company is engaged in the sales of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicine.
Employees
573
Date Price Change Volume
02/11/26 HK$0.0890 0.00% 0
30/10/26 HK$0.0890 0.00% 0
29/10/26 HK$0.0890 0.00% 0
28/10/26 HK$0.0890 0.00% 0
27/10/26 HK$0.0890 -1.11% 20,000

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tianda Pharmaceuticals Limited